Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.

Morgan, R J; Braly, P; Cecchi, G; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Parker, P; Stein, A; Cho, J; Smith, E; Coluzzi, P; Najera, L; Johnson, D; Womack, E; Doroshow, J H

Morgan, R J; Braly, P; Cecchi, G; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Parker, P; Stein, A; Cho, J; Smith, E; Coluzzi, P; Najera, L; Johnson, D; Womack, E; Doroshow, J H.

Affiliation

Morgan RJ; Department of Gynecologic Oncology, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, California 91010, USA.

Gynecol Oncol ; 75(3): 419-26, 1999 Dec.

Article in En | MEDLINE | ID: mdl-10600300

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Ovarian Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms/mortality

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links